As shown in Figure 2A, 2 μM JapA significantly reduced the MDM2 expression levels in MCF-7, MCF-7/p53−/−(p53 knockdown), MDA-MB-231, and MDA-MB-468 (p53 mutant) breast cancer cell lines. Here, TP53 is linked to breast cancer.